Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis
- Qingliang Ma
- Shiyu Wang
- Hong Xue
- Linhui Ni
- Putao Yuan
- Yang Shen
- Bingjie Zheng
- Qingqing Wang
- Jiateng Zhang
- Haoming Wang
- Hongwei Xie
- Chao Jiang
- An Qin
- Shunwu Fan
- Ziang Xie
- Zhiwei Jie
2025-08-06